EPID-27 GLIOSTRY (GLIOBLASTOMA REGISTRY) OF THE AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY): ANALYSIS OF FACTORS INFLUENCING SURVIVAL IN GLIOBLASTOMA PATIENTS RECEIVING THE NITROSOUREA FOTEMUSTINE AT FIRST PROGRESSION FOLLOWING THE STUPP REGIMEN

Lignende værker

• P08.33 GLIOSTRY (Glioblastoma Registry) of the AINO (Italian Association of Neuro-Oncology): final analysis of factors influencing survival in glioblastoma patients receiving the nitrosourea fotemustine at first progression following chemoradiation.
  af: Rudà, R., et al.
  Udgivet: (2016)
• Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
  af: Soffietti, Riccardo, et al.
  Udgivet: (2013)
• Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
  af: Santoni, Matteo, et al.
  Udgivet: (2013)
• O10.06 A PHASE II STUDY OF AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY) ON BEVACIZUMAB AND FOTEMUSTINE FOR RECURRENT GLIOBLASTOMA: OUTCOME, PATTERNS OF RELAPSE AND SALVAGE TREATMENTS
  af: Trevisan, E., et al.
  Udgivet: (2014)
• EPID-16. EPIDEMIOLOGICAL TRENDS FOR LONGER TERM GBM SURVIVORS POST STUPP
  af: Forner, Samantha, et al.
  Udgivet: (2020)